This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Miltenyi Biotec, Gmbh. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Biography of Inventor Siegfried Kohler
Introduction: Siegfried Kohler is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of immunology, particularly in the identification and separation of T-cells.
Latest Patents: Kohler holds a patent for a method that identifies and separates non-regulatory T-cells from a mixture of regulatory T-cells. This innovative method utilizes the CD154 molecule (CD40 ligand) to deplete CD154+ T-cells from the mixture. Additionally, it involves the positive selection of regulatory T-cells using specific markers such as CD25, GITR, and CTLA4. The invention also includes a kit that comprises an antibody for detecting CD154 and additional antibodies for detecting activated or non-activated regulatory T-cells.
Career Highlights: Siegfried Kohler is currently associated with Miltenyi Biotec GmbH, where he continues to advance research in immunology. His work has been instrumental in developing techniques that enhance the understanding of T-cell functions.
Collaborations: Throughout his career, Kohler has collaborated with esteemed colleagues, including Anne Schönbrunn and Dan Robin Miller. These collaborations have contributed to the success of his research and innovations.
Conclusion: Siegfried Kohler's contributions to the field of immunology through his innovative patent demonstrate his commitment to advancing
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile